Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.4B | 1.5B | 1.5B |
Cost of revenue | 675M | 705M | 623M | 618M |
Gross profit | 905M | 727M | 847M | 864M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | 53M |
Other operating expenses | 49M | 47M | 59M | 53M |
Operating income | 273M | 203M | 274M | 294M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 609M | 509M | 514M | 489M |
Other income expense | 142M | 142M | 192M | 126M |
Pretax income | -194M | -27M | -48M | -69M |
Tax provision | -86M | -215M | -9M | 19M |
Net income | -108M | 188M | -39M | -88M |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 749M | 178M | 794M | 821M |
Net income from continuing op. | -108M | 188M | -39M | -88M |
Minority interests | 15M | -197M | -44M | 18M |
Preferred stock dividends | — | — | — | — |